A major discovery in cancer study is arising with the use of nanobodies to re-engage dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in several forms of tumors, causing uncontrolled https://bookmarkswing.com/story23745581/nanobodies-reactivate-p53-new-potential-approach-for-tumor-therapy